• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ERK5 活性调节作为一种治疗癌症的策略。

Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy.

机构信息

Cancer Research Horizons Therapeutic Innovation, Newcastle Drug Discovery Group, Newcastle University Centre for Cancer, School of Natural and Environmental Sciences, Newcastle University, Bedson Building, Newcastle upon Tyne NE1 7RU, United Kingdom.

Cancer Research Horizons Therapeutic Innovation, Newcastle Drug Discovery Group, Translational and Clinical Research Institute, Paul O'Gorman Building, Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, United Kingdom.

出版信息

J Med Chem. 2023 Apr 13;66(7):4491-4502. doi: 10.1021/acs.jmedchem.3c00072. Epub 2023 Apr 1.

DOI:10.1021/acs.jmedchem.3c00072
PMID:37002872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10108346/
Abstract

The extracellular signal-regulated kinase 5 (ERK5) signaling pathway is one of four conventional mitogen-activated protein (MAP) kinase pathways. Genetic perturbation of ERK5 has suggested that modulation of ERK5 activity may have therapeutic potential in cancer chemotherapy. This Miniperspective examines the evidence for ERK5 as a drug target in cancer, the structure of ERK5, and the evolution of structurally distinct chemotypes of ERK5 kinase domain inhibitors. The emerging complexities of ERK5 pharmacology are discussed, including the confounding phenomenon of paradoxical ERK5 activation by small-molecule ERK5 inhibitors. The impact of the recent development and biological evaluation of potent and selective bifunctional degraders of ERK5 and future opportunities in ERK modulation are also explored.

摘要

细胞外信号调节激酶 5（ERK5）信号通路是四条传统的有丝分裂原激活蛋白（MAP）激酶通路之一。ERK5 的遗传扰动表明，ERK5 活性的调节可能在癌症化疗中有治疗潜力。本专论考察了 ERK5 作为癌症药物靶点的证据、ERK5 的结构以及结构上不同的 ERK5 激酶结构域抑制剂的化学型的演变。讨论了 ERK5 药理学的新兴复杂性，包括小分子 ERK5 抑制剂引起的矛盾性 ERK5 激活的混淆现象。还探讨了最近强效和选择性 ERK5 双功能降解物的开发和生物学评估以及 ERK 调节的未来机会的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/a61541663b0c/jm3c00072_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/9d1b59678573/jm3c00072_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/49c60d848b1c/jm3c00072_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/dda33014dbb5/jm3c00072_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/0ff2459ee1ff/jm3c00072_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/b9195b3292dc/jm3c00072_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/8b00582da438/jm3c00072_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/7c57205ff969/jm3c00072_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/8c4d70c44604/jm3c00072_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/a61541663b0c/jm3c00072_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/9d1b59678573/jm3c00072_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/49c60d848b1c/jm3c00072_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/dda33014dbb5/jm3c00072_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/0ff2459ee1ff/jm3c00072_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/b9195b3292dc/jm3c00072_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/8b00582da438/jm3c00072_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/7c57205ff969/jm3c00072_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/8c4d70c44604/jm3c00072_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9620/10108346/a61541663b0c/jm3c00072_0009.jpg

相似文献

1
Modulation of ERK5 Activity as a Therapeutic Anti-Cancer Strategy.ERK5 活性调节作为一种治疗癌症的策略。
J Med Chem. 2023 Apr 13;66(7):4491-4502. doi: 10.1021/acs.jmedchem.3c00072. Epub 2023 Apr 1.
2
Differential regulation of mitogen-activated protein kinases ERK1/2 and ERK5 by neurotrophins, neuronal activity, and cAMP in neurons.神经营养因子、神经元活性和环磷酸腺苷（cAMP）对神经元中丝裂原活化蛋白激酶ERK1/2和ERK5的差异调节
J Neurosci. 2001 Jan 15;21(2):434-43. doi: 10.1523/JNEUROSCI.21-02-00434.2001.
3
MAPK signalling: ERK5 versus ERK1/2.丝裂原活化蛋白激酶信号传导：细胞外信号调节激酶5与细胞外信号调节激酶1/2
EMBO Rep. 2006 Aug;7(8):782-6. doi: 10.1038/sj.embor.7400755.
4
Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects.自杀者海马体中异常的细胞外信号调节激酶（ERK）5信号传导。
Neuropsychopharmacology. 2007 Nov;32(11):2338-50. doi: 10.1038/sj.npp.1301372. Epub 2007 Mar 7.
5
Cell-cycle arrest by PD184352 requires inhibition of extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1.PD184352引起的细胞周期停滞需要抑制细胞外信号调节激酶（ERK）1/2，而不是ERK5/BMK1。
Biochem J. 2002 Sep 1;366(Pt 2):673-80. doi: 10.1042/BJ20020372.
6
Small molecule ERK5 kinase inhibitors paradoxically activate ERK5 signalling: be careful what you wish for….小分子 ERK5 激酶抑制剂出人意料地激活了 ERK5 信号通路：小心你所期望的……
Biochem Soc Trans. 2020 Oct 30;48(5):1859-1875. doi: 10.1042/BST20190338.
7
BAFF activation of the ERK5 MAP kinase pathway regulates B cell survival.BAFF对ERK5丝裂原活化蛋白激酶途径的激活调节B细胞存活。
J Exp Med. 2015 Jun 1;212(6):883-92. doi: 10.1084/jem.20142127. Epub 2015 May 18.
8
Discovery of a Gatekeeper Residue in the C-Terminal Tail of the Extracellular Signal-Regulated Protein Kinase 5 (ERK5).细胞外信号调节激酶 5（ERK5）胞外尾端的关键残基的发现。
Int J Mol Sci. 2020 Jan 31;21(3):929. doi: 10.3390/ijms21030929.
9
Expressed in the yeast Saccharomyces cerevisiae, human ERK5 is a client of the Hsp90 chaperone that complements loss of the Slt2p (Mpk1p) cell integrity stress-activated protein kinase.在酿酒酵母中表达时，人ERK5是热休克蛋白90（Hsp90）伴侣蛋白的一个客户蛋白，它可补充Slt2p（Mpk1p）细胞完整性应激激活蛋白激酶缺失的功能。
Eukaryot Cell. 2006 Nov;5(11):1914-24. doi: 10.1128/EC.00263-06. Epub 2006 Sep 1.
10
ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.ERK5 抑制通过调节 Smad3 乙酰化改善肺纤维化。
Am J Pathol. 2013 Dec;183(6):1758-1768. doi: 10.1016/j.ajpath.2013.08.014. Epub 2013 Oct 1.

引用本文的文献

1
Nanocarrier-Based Systems for Targeted Delivery: Current Challenges and Future Directions.基于纳米载体的靶向递送系统：当前挑战与未来方向
MedComm (2020). 2025 Aug 21;6(9):e70337. doi: 10.1002/mco2.70337. eCollection 2025 Sep.
2
Anti-cancer Effects of 1,4-Dialkoxynaphthalene-Imidazolium Salt Derivatives through ERK5 kinase activity inhibition.1,4-二烷氧基萘-咪唑盐衍生物通过抑制ERK5激酶活性发挥抗癌作用。
Sci Rep. 2025 Apr 20;15(1):13648. doi: 10.1038/s41598-025-96306-x.
3
A first-in-class selective inhibitor of ERK1/2 and ERK5 overcomes drug resistance with a single-molecule strategy.

本文引用的文献

1
Inhibiting ERK5 overcomes breast cancer resistance to anti-HER2 therapy by targeting the G1/S cell cycle transition.抑制 ERK5 通过靶向 G1/S 细胞周期转换克服乳腺癌对抗 HER2 治疗的耐药性。
Cancer Res Commun. 2022 Mar 10;2(3):131-145. doi: 10.1158/2767-9764.CRC-21-0089.
2
Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferation.ERK5 的急性药理学降解不会抑制细胞免疫反应或增殖。
Cell Chem Biol. 2022 Nov 17;29(11):1630-1638.e7. doi: 10.1016/j.chembiol.2022.09.004. Epub 2022 Oct 10.
3
The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.
一种一流的ERK1/2和ERK5选择性抑制剂通过单分子策略克服耐药性。
Signal Transduct Target Ther. 2025 Feb 20;10(1):70. doi: 10.1038/s41392-025-02169-z.
4
Special Issue: MAPK Signaling Cascades in Human Health and Diseases.特刊：MAPK 信号级联在人类健康和疾病中的作用
Int J Mol Sci. 2024 Oct 18;25(20):11226. doi: 10.3390/ijms252011226.
5
ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer.ERK5 抑制克服了驱动非小细胞肺癌的突变 KRAS 中的 FAK 抑制剂耐药性。
EMBO Mol Med. 2024 Oct;16(10):2402-2426. doi: 10.1038/s44321-024-00138-7. Epub 2024 Sep 13.
ERK5/NF-κB 信号通路靶向子宫内膜癌的增殖和存活。
Cell Mol Life Sci. 2022 Sep 19;79(10):524. doi: 10.1007/s00018-022-04541-6.
4
Parallel Optimization of Potency and Pharmacokinetics Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain Inhibitor.功效和药代动力学的平行优化导致发现吡咯羧酰胺 ERK5 激酶结构域抑制剂。
J Med Chem. 2022 May 12;65(9):6513-6540. doi: 10.1021/acs.jmedchem.1c01756. Epub 2022 Apr 25.
5
ERK5 Inhibition Induces Autophagy-Mediated Cancer Cell Death by Activating ER Stress.ERK5抑制通过激活内质网应激诱导自噬介导的癌细胞死亡。
Front Cell Dev Biol. 2021 Nov 4;9:742049. doi: 10.3389/fcell.2021.742049. eCollection 2021.
6
Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21.ERK5 抑制通过细胞周期蛋白依赖性激酶抑制剂 p21 诱导黑色素瘤细胞衰老。
Cancer Res. 2022 Feb 1;82(3):447-457. doi: 10.1158/0008-5472.CAN-21-0993. Epub 2021 Nov 19.
7
ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression.ERK5 调节 IL-6 的分泌并有助于肿瘤诱导的免疫抑制。
Cell Death Dis. 2021 Oct 20;12(11):969. doi: 10.1038/s41419-021-04257-8.
8
Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer.临床、遗传和药理学数据支持将MEK5/ERK5模块作为肺癌治疗靶点。
NPJ Precis Oncol. 2021 Aug 17;5(1):78. doi: 10.1038/s41698-021-00218-8.
9
The MEK5/ERK5 Pathway in Health and Disease.MEK5/ERK5 通路在健康和疾病中的作用。
Int J Mol Sci. 2021 Jul 15;22(14):7594. doi: 10.3390/ijms22147594.
10
The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion.细胞外调节蛋白激酶 5（ERK5）通过粘着斑激酶（FAK）介导的细胞黏附调控作用增加三阴性乳腺癌的转移负荷。
Oncogene. 2021 Jun;40(23):3929-3941. doi: 10.1038/s41388-021-01798-2. Epub 2021 May 12.